@article{59fc9e75ddb74085a1dcf21536cb0392,
title = "Higher risk of tuberculosis reactivation when anti-TNF is combined with immunosuppressive agents: a systematic review of randomized controlled trials",
abstract = "Treatment with tumour necrosis factor antagonists (anti-TNF) has been recognized as a risk factor for tuberculosis (TB) reactivation. Our aim was to evaluate risk of TB reactivation in rheumatologic and non-rheumatologic diseases treated with the same anti-TNF agents with and without concomitant therapies.",
keywords = "Ankylosing spondylitis, anti-TNF, inflammatory bowel diseases, methotrexate, psoriasis, rheumatoid arthritis, tuberculosis, Ankylosing spondylitis, anti-TNF, inflammatory bowel diseases, methotrexate, psoriasis, rheumatoid arthritis, tuberculosis",
author = "Roberto Lorenzetti and Angelo Zullo and Lorenzo Ridola and Diamanti, {Andrea Picchianti} and Bruno Lagan{\`a} and Luigi Gatta and Alberto Migliore and Alessandro Armuzzi and Cesare Hassan and Vincenzo Bruzzese",
year = "2014",
doi = "10.3109/07853890.2014.941919",
language = "English",
volume = "46",
pages = "547--554",
journal = "Annals of Medicine",
issn = "0785-3890",
publisher = "Informa Healthcare",
}
